ECSP993277A - 4,5- AZOLO- OXINDOLES - Google Patents

4,5- AZOLO- OXINDOLES

Info

Publication number
ECSP993277A
ECSP993277A ECSP993277A ECSP993277A EC SP993277 A ECSP993277 A EC SP993277A EC SP993277 A ECSP993277 A EC SP993277A EC SP993277 A ECSP993277 A EC SP993277A
Authority
EC
Ecuador
Prior art keywords
oxindoles
azolo
cdks
graph
already
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Kin Chun Luk
Steven Gregory Mischke
Christophe Michoud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993277 priority Critical patent/ECSP993277A/en
Publication of ECSP993277A publication Critical patent/ECSP993277A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

4,5-azolo-oxindoles nuevos con la fórmula (gráfico), donde R1, R2, Y, Z ya tienen el significado indicado en la especificación, inhiben las quinasas dependientes de ciclina (CDKs), en partcular CDK2, y son útiles en el tratamiento o control de los desórdenes proliferativos celulares, en particular el cáncer.New 4,5-azolo-oxindoles with the formula (graph), where R1, R2, Y, Z already have the meaning indicated in the specification, inhibit cyclin-dependent kinases (CDKs), in particular CDK2, and are useful in the treatment or control of cellular proliferative disorders, in particular cancer.

ECSP993277 1999-12-17 1999-12-17 4,5- AZOLO- OXINDOLES ECSP993277A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993277 ECSP993277A (en) 1999-12-17 1999-12-17 4,5- AZOLO- OXINDOLES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993277 ECSP993277A (en) 1999-12-17 1999-12-17 4,5- AZOLO- OXINDOLES

Publications (1)

Publication Number Publication Date
ECSP993277A true ECSP993277A (en) 2000-08-18

Family

ID=42044266

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993277 ECSP993277A (en) 1999-12-17 1999-12-17 4,5- AZOLO- OXINDOLES

Country Status (1)

Country Link
EC (1) ECSP993277A (en)

Similar Documents

Publication Publication Date Title
PA8537501A1 (en) NAFTOSTIRILS
ECSP088598A (en) DERIVATIVES OF PIRIDAZINONA
CY1109764T1 (en) Substituted benzazoles and their use as RAF suspensions
CY1120257T1 (en) PYROLOL [2,3b] PYRIDIN-4-GLAMES AND PYROLOL [2,3b] PYRIMIDIN-4-GLAMES AS JANUS MODELS
BRPI0412993A (en) akt activity inhibitors
CY1106766T1 (en) PYRIDINE DERIVATIVES AS RAF KINASE INHIBITORS
DK1419154T3 (en) Rapamycin 29-enols
CY1106816T1 (en) 3,4-DIHYDRO-1H-PYRIMIDE [4,5-D] PYRIMIDIN-2-ONE 1,5-DISUBTITUTED COMPOUNDS AND THEIR USE FOR THE THERAPEUTIC TREATMENT OF DISEASES MEDIATED BY CSBP/P38 KINASE
ATE414514T1 (en) COMBINATIONS CONTAINING AN ANTIDIARRHOIC AND EPOTHILONE OR AN EPOTHILONE DERIVATIVE
ES2187785T3 (en) 3,5-DIFENIL-1,2,4-SUBSTITUTED TRIAZOLS AND ITS USE AS PHARMACEUTICAL METAL BURNERS.
NO20014560L (en) Quinasolines and their therapeutic use
CY1110914T1 (en) TWIN-CYCLOTS ACTIVE AS CHINESE RESTRICTIONS, PROCESSING FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM
CY1107475T1 (en) RO-MOTION SUSPENSIONS
CY1105349T1 (en) THIAZOLYL TEC FAMILY TYROKINASE INHIBITORS
CY1108109T1 (en) USE CCI-779 AS ANTI-PLASTIC FACTOR
CY1114133T1 (en) Substituted c-phenyl-D-lactams and their related uses
IS6918A (en) Treatment of difficult tumors with the use of epothilone derivatives
CY1110666T1 (en) PYRAZOLOPYRIMIDINES SUITABLE FOR CANCER DISEASE TREATMENT
CY1112235T1 (en) 3,6-Dihydro-2-oxo-6H- (1,3,4) -thiadiazine derivative
AR021695A1 (en) 4,5-PIRAZINOXINDOLES, PHARMACEUTICAL COMPOSITION AND USE
NO20041214L (en) Substituted benzimidazole compounds and their use in the treatment of cancer
CY1105803T1 (en) COMPOSITION OF PEPILAMVANOUS CAMPTOTHEKIN AND A PYRIMIDINE DERIVATIVE FOR THE TREATMENT OF CANCER
SE0003476D0 (en) Compounds
CL2004000877A1 (en) PHARMACEUTICAL COMBINATION THAT INCLUDES 8A) MELATONIN AND MELATONINE AGONISTS, AND NICOTINE AND NICOTINE RECEIVING AGONISTS; PHARMACEUTICAL KIT, AND; USE IN THE TREATMENT OF INSOMNIUM, COGNITIVE DIFFICULTIES AND MEMORY DIFFICULTIES; FARMACEU KIT
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE